Investor

»Investor
6 11, 2017

Eiger BioPharmaceuticals to Participate in Upcoming Investor Conferences

2017-11-06T13:14:37+00:00

Eiger BioPharmaceuticals to Participate in Upcoming Investor Conferences PALO ALTO, Calif. – November 6, 2017 – Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for orphan diseases, announced today that David Cory, President and CEO of Eiger, will participate and present in three upcoming investor conferences. Jefferies 2017 London Healthcare Conference, [...]

Eiger BioPharmaceuticals to Participate in Upcoming Investor Conferences 2017-11-06T13:14:37+00:00
31 10, 2017

Eiger BioPharmaceuticals Announces Closing of Public Offering of Common Stock and Exercise In Full of Underwriter’s Option to Purchase Additional Shares

2017-10-31T21:11:35+00:00

Eiger BioPharmaceuticals Announces Closing of Public Offering of Common Stock and Exercise In Full of Underwriter’s Option to Purchase Additional Shares PALO ALTO, Calif., October 31, 2017 /PR Newswire/ — Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR), a clinical-stage biopharmaceutical company focused on the development and commercialization of targeted therapies for rare diseases, today announced the closing [...]

Eiger BioPharmaceuticals Announces Closing of Public Offering of Common Stock and Exercise In Full of Underwriter’s Option to Purchase Additional Shares 2017-10-31T21:11:35+00:00
27 10, 2017

Eiger BioPharmaceuticals Announces Pricing of Public Offering of Common Stock

2017-10-27T15:17:14+00:00

Eiger BioPharmaceuticals Announces Pricing of Public Offering of Common Stock PALO ALTO, Calif., October 27, 2017 /PR Newswire/ — Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR), a clinical-stage biopharmaceutical company focused on the development and commercialization of targeted therapies for rare diseases, today announced the pricing of its underwritten public offering of 1,854,749 shares of its common [...]

Eiger BioPharmaceuticals Announces Pricing of Public Offering of Common Stock 2017-10-27T15:17:14+00:00
26 10, 2017

Eiger BioPharmaceuticals Announces Proposed Public Offering of Common Stock

2017-10-26T21:05:24+00:00

Eiger BioPharmaceuticals Announces Proposed Public Offering of Common Stock PALO ALTO, Calif., October 26, 2017 /PR Newswire/ – Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR), a clinical-stage biopharmaceutical company focused on the development and commercialization of targeted therapies for rare diseases, today announced that it intends to offer and sell, subject to market conditions, shares of its common [...]

Eiger BioPharmaceuticals Announces Proposed Public Offering of Common Stock 2017-10-26T21:05:24+00:00